Association of Sterile Pyuria and Coronary Artery Aneurysm in Kawasaki Syndrome
Abstract
Kawasaki disease (KD) is an inflammatory multiorgan disease of unknown etiology. The most dramatic organ involved is the heart. There were a few studies about cardiac involvement and sterile pyuria. This study guides to determine if sterile pyuria is associated with coronary artery aneurysm (CAA) in KD patients and to consider it as a predicting factor for coronary artery involvement. Forty seven patients with KD were studied by echocardiography in admission and one month later. Urine analysis, complete blood count, erythrocyte sedimentation rate and C-reactive protein were measured in admission. Data were analyzed using SPSS-14 software. Patients' age was ranged from 13 month to 7 years old (mean age of 3.43 ± 1.54 years). Thirty patients (63.8%) were male and 17 patients (36.1%) were female. Cardiac involvement was detected in 32 patients (68%) using echocardiography, of which CAA was reported in 8 cases (17%). Six of CAA (75%) were in association with sterile pyuria, although it was statistically insignificant (P>0.05). Although the majority of patients with CAA had sterile pyuria, this association is not statistically significant, thus it couldn't be considered as a predicting factor for CAA.
Council on Cardiovascular Disease in the Young; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; American Heart Association. Diagnostic guidelines for Kawasaki disease. Circulation 2001;103(2):335-6.
Taubert KA. Epidemiology of Kawasaki disease in the United States and worldwide. Prog Pediatr Cardiol 1997;6:181-5.
Melish M, Hicks R, Larson E, Mucocutaneous lymph node syndrome in the United States. Am J Dis Child 1976;130(6):599-607.
Haftel HM. Rheumatic disease of childhood. In: Kliegman RM, Marcdante KJ, Jenson HB, Behrman RE, editors. Nelson Essentials of Pediatrics. 5th ed. Philadelphia, PA: Saunders Elsevier; 2006. p. 426-44.
Valentini RP, Smoyer WE. Renal vasculitis. In: Avner E, Harmon W, Niaudet P, editors. Pediatric Nephrology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 835-50.
Han RK, Sinclair B, Newman A, Silverman ED, Taylor GW, Walsh P, McCrindle BW. Recognition and management of Kawasaki disease. CMAJ 2000;162(6):807-12.
Helle R, Alsaker T, Norgård G. Risk factors in Kawasaki's syndrome. Tidsskr Nor Laegeforen 2004;124(13-14):1764-6.
Rowley AH, Shulman ST. Kawasaki syndrome. Clin Microbiol Rev 1998;11(3):405-14.
Aarabi Moghadam MY, Mearji M, Sayadpoor K. Study of cardiac involvement prevalence in 61 pediatric case of Kawasaki disease. IJMS 2004;11:361-6.
Yanagawa H, Nakamura Y, Yashiro M, Oki I, Hirata S, Zhang T, Kawasaki T. Incidence survey of Kawasakidisease in 1997 and 1998 in Japan. Pediatrics 2001;107(3):E33.
Pfafferott C, Wirtzfeld A, Permanetter B. Atypical Kawasaki syndrome: how many symptoms have to be present? Heart 1997;78(6):619-21.
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, et al; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110(17):2747-71.
Belay ED, Maddox RA, Holman RC, Curns AT, Ballah K, Schonberger LB. Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J 2006;25(3):245-9.
Stamos JK, Corydon K, Donaldson J, Shulman ST. Lymphadenitis as the dominant manifestation of Kawasaki disease. Pediatrics 1994;93(3):525-8.
Mason WH, Schneider T, Takahashi M. The epidemiology and etiology of Kawasaki disease. Cardiol Young 1991;1:196-205.
Rowley AH, Shulman ST. Kawasaki disease. In: Behrman RE, Kliegman RM, Jenson HB, editors. Nelson's Text Book of Pediatrics. 17th ed. Philadelphia, PA: WB Saunders; 2004. p. 823-6.
Takahashi M, Newburger JW. Kawasaki disease (mucocutaneous lymph node syndrome). In: Allen HD, Gutgesell HD, Clark EB, Driscoll DJ, editors. Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adults. 7th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2008. p. 1242-55.
Watanabe T, Abe Y, Sato S, Uehara Y, Ikeno K, Abe T. Sterile pyuria in patients with Kawasaki disease originatesfrom both the urethra and the kidney. Pediatr Nephrol 2007;22(7):987-91.
Wu CY, Hsieh KS, Chiou YH, Wang RS, Huang IF, Lee WY, Chiou CC. Prolonged fever and pyuria: a urinary tract infection presentation of incomplete Kawasaki disease. Acta Paediatr 2005;94(3):375-7.
Nakamura Y, Yashiro M, Uehara R, Oki I, Watanabe M, Yanagawa H. Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006. J Epidemiol 2008;18(4):167-72.
Sadeghi E, Amin R, Ajamee GH. Kawasaki syndrome: theIranian experience. East Mediterr Health J 2001;7(1-2):16-25.
Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T, Turner CL. Kawasaki disease: A briefhistory. Pediatrics 2000;106(2):E27.
Wirojanan J, Sopontammarak S, Vachvanichsanong P. Sterile pyuria in Kawasaki disease. Pediatr Nephrol 2004;19(3):363.
Huang WC, Huang LM, Chang IS, Chang LY, Chiang BL, Chen PJ, Wu MH, Lue HC, Lee CY; Kawasaki Disease Research Group. Epidemiologic features of Kawasakidisease in Taiwan, 2003-2006. Pediatrics2009;123(3):e401-5.
Yeo Y, Kim T, Ha K, Jang G, Lee J, Lee K, Son C, Lee J. Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor. Eur J Pediatr 2009;168(2):157-62.
Files | ||
Issue | Vol 49, No 9 (2011) | |
Section | Original Article(s) | |
Keywords | ||
Mucocutaneous lymph node syndrome Coronary vessels Pyuria Aneurysm Fever |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |